Literature DB >> 8746116

Chemokines: progress toward identifying molecular targets for therapeutic agents.

O M Howard1, A Ben-Baruch, J J Oppenheim.   

Abstract

Leukocyte migration towards injury sites is directed by the interaction of chemokines with their receptors. The stages of migration are closely regulated events that involve chemokine-induced leukocyte adhesion, diapedesis and homing. Current research suggests a pathophysiological role for chemokines in diverse inflammatory states arising from viral, bacterial and parasitic infection, allergic and asthmatic reactions, atherosclerosis and arthritis. A role for chemokines in tumor immunity and angiogenesis has recently been demonstrated. A basis for the rational design of chemokine antagonists is emerging from a knowledge of tertiary structures and mutational analysis of chemokine ligands and receptors. Here, we discuss advances in knowledge about chemokine structure and function, with emphasis on potential therapeutic agents.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8746116     DOI: 10.1016/0167-7799(96)80920-6

Source DB:  PubMed          Journal:  Trends Biotechnol        ISSN: 0167-7799            Impact factor:   19.536


  24 in total

Review 1.  Current status and challenges of cytokine pharmacology.

Authors:  Z Zídek; P Anzenbacher; E Kmonícková
Journal:  Br J Pharmacol       Date:  2009-04-03       Impact factor: 8.739

2.  beta-Chemokines enhance parasite uptake and promote nitric oxide-dependent microbiostatic activity in murine inflammatory macrophages infected with Trypanosoma cruzi.

Authors:  J C Aliberti; F S Machado; J T Souto; A P Campanelli; M M Teixeira; R T Gazzinelli; J S Silva
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

3.  The chemokine monocyte chemoattractant protein-1 induces functional responses through dimerization of its receptor CCR2.

Authors:  J M Rodríguez-Frade; A J Vila-Coro; A M de Ana; J P Albar; C Martínez-A; M Mellado
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

4.  The amino-terminal domain of the CCR2 chemokine receptor acts as coreceptor for HIV-1 infection.

Authors:  J M Frade; M Llorente; M Mellado; J Alcamí; J C Gutiérrez-Ramos; A Zaballos; G Real; C Martínez-A
Journal:  J Clin Invest       Date:  1997-08-01       Impact factor: 14.808

5.  Vitamin A modifies the intestinal chemokine and cytokine responses to norovirus infection in Mexican children.

Authors:  Kurt Z Long; Coralith Garcia; GwangPyo Ko; Jose I Santos; Abdullah Al Mamun; Jorge L Rosado; Herbert L DuPont; Nanda Nathakumar
Journal:  J Nutr       Date:  2011-03-16       Impact factor: 4.798

6.  The equine herpesvirus 2 E1 open reading frame encodes a functional chemokine receptor.

Authors:  G Camarda; G Spinetti; G Bernardini; C Mair; N Davis-Poynter; M C Capogrossi; M Napolitano
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

7.  Characterization of the in vitro anti-inflammatory activity of AL-5898 and related benzopyranyl esters and amides.

Authors:  Karen C David; Milton T Brady; Lori K Weimer; Mark R Hellberg; Jon C Nixon; Gustav Graff
Journal:  Inflammation       Date:  2003-02       Impact factor: 4.092

8.  Soluble mimics of a chemokine receptor: chemokine binding by receptor elements juxtaposed on a soluble scaffold.

Authors:  Amita Datta; Martin J Stone
Journal:  Protein Sci       Date:  2003-11       Impact factor: 6.725

Review 9.  Chemokine receptor trio: CXCR3, CXCR4 and CXCR7 crosstalk via CXCL11 and CXCL12.

Authors:  Anup Kumar Singh; Rakesh Kumar Arya; Arun Kumar Trivedi; Sabyasachi Sanyal; Rathindranath Baral; Olivier Dormond; David M Briscoe; Dipak Datta
Journal:  Cytokine Growth Factor Rev       Date:  2012-09-16       Impact factor: 7.638

10.  Pathogenesis of atherosclerosis: A multifactorial process.

Authors:  Raja B Singh; Sushma A Mengi; Yan-Jun Xu; Amarjit S Arneja; Naranjan S Dhalla
Journal:  Exp Clin Cardiol       Date:  2002
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.